Skip to content
DataLookout
Menu

NCT07889804

Quality of Life in Patients With Post-Sepsis Syndrome

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Number of deaths and hospital readmissions during the 12-month follow-up period
Timeframe: 1-12 month

Secondary (3)

Overall health status and quality of life during the post-sepsis period (PROMIS score)
Severity of depressive symptoms during the post-sepsis period (PHQ-9 score)
Severity of anxiety symptoms during the post-sepsis period (GAD-7 score)

Arms and interventions

Baseline therapy

Patients who received standard therapy for sepsis. RRT or plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.

Baseline therapy + Efferon LPS

Patients who received Efferon® LPS hemoadsorption during treatment for sepsis, either alone or in combination with renal replacement therapy (RRT). Concomitant plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.

Devices: Efferon LPS

Sites

5 sites in 1 country